medRxiv
Routine data helped target frailty checks in chronic disease
In the model’s validation sample, screening the highest-risk 20% identified 55.6% of frailty cases, a 2.78-fold improvement over random screening.In the model’s validation sample, screening the highest-risk 20% identified 55.6% of frailty cases, a 2.78-fold improvement over random screening.
Preprint: cross-sectional study of 281,729 peopleBiomarkers